Immediate Impact

72 standout
Sub-graph 1 of 23

Citing Papers

Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial
2023 Standout
Systematic literature review of schizophrenia clinical practice guidelines on acute and maintenance management with antipsychotics
2022 Standout
23 intermediate papers

Works of Marc Eneman being referenced

Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: a multicentre double‐blind comparative study
1992
Ventricular enlargement, clinical correlates and treatment outcome in chronic schizophrenic inpatients
1992

Author Peers

Author Last Decade Papers Cites
Marc Eneman 20 11 76 232 72 12 309
Bengt Ekblom 18 7 43 192 60 20 311
J. Schwitzer 9 8 50 207 85 19 308
Marie Starzer 40 4 56 189 79 13 299
C.U. Correll 10 3 73 302 77 16 361
Michael Alfred Peszke 20 4 104 218 124 27 366
Patricia L. Gilbert 14 23 93 302 99 5 349
Christian G. Widschwendter 14 8 43 200 63 18 310
José Luis Gutiérrez 14 7 58 242 99 6 338
J.L. Ayuso-Gutiérrez 26 9 43 251 104 13 335
J. W. Affleck 29 13 57 204 118 14 342

All Works

Loading papers...

Rankless by CCL
2026